Does a Combination Regimen of Thyroxine (T4) and 3,5,3′-Triiodothyronine Improve Depressive Symptoms Better Than T4Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Some hypothyroid patients receiving levothyroxine replacement therapy complain of depressive symptoms despite normal TSH measurements. It is not known whether adding T(3) can reverse such symptoms. We randomized 40 individuals with depressive symptoms who were taking a stable dose of levothyroxine for treatment of hypothyroidism (excluding those who underwent thyroidectomy or radioactive iodine ablation of the thyroid) to receive T(4) plus placebo or the combination of T(4) plus T(3) in a double-blind manner for 15 wk. Participants receiving combination therapy had their prestudy dose of T(4) dropped by 50%, and T(3) was started at a dose of 12.5 micro g, twice daily. T(4) and T(3) doses were adjusted to keep goal TSH concentrations within the normal range. Compared with the group taking T(4) alone, the group taking both T(4) plus T(3) did not report any improvement in self-rated mood and well-being scores that included all subscales of the Symptom Check-List-90, the Comprehensive Epidemiological Screen for Depression, and the Multiple Outcome Study (P > 0.05 for all indexes). In conclusion, the current data do not support the routine use of combined T(3) and T(4) therapy in hypothyroid patients with depressive symptoms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another trial was conducted in those with depressive symptoms (60).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [60]
In the citing paper
“Eleven trials were 5–16 weeks (23,46,49,51–53,58–60,71,79), three trials were 4–6 months (17,48,78), and one trial was 1 year in duration (47).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [60]
In the citing paper
“There was no significant difference in Heart Rate, SHBG, TSH, Lipid profile, TSQ-36, and BDI Score.”
In the citing paper
“Most of the included studies are insignificant [9, 12–18] except for two studies, one showed a lower TSH, and the other showed a higher TSH [19, 20].”
In the citing paper
“The daily L-T3 dose was administered as a single dose in all trials except four, in which it was divided in two doses [37,40,42,43] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [43]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
A scaled version of the General Health Questionnaire
Goldberg, D. P., & Hillier, V. F. (1979) · Psychological Medicine · doi:10.1017/s0033291700021644 · Cited by 5,459
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 4,633
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale
Derogatis, L. R., Rickels, K., & Rock, A. F. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.128.3.280 · Cited by 2,298
Hays, R. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950130011002 · Cited by 841
The Center for Epidemiologic Studies Depression Scale: its use in a community sample
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.1.41 · Cited by 804
McHorney, C. A., Ware, J. E., Rogers, W., Raczek, A. E., & Lu, J. F. R. (1992) · Medical Care · doi:10.1097/00005650-199205001-00025 · Cited by 740
Conversion of Thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects
Braverman, L. E., Ingbar, S. H., & Sterling, K. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106304 · Cited by 485
Cited by
Items 101–174 of 174
Dosage Recommendations for Combination Regimen of Thyroxine and 3,5,3′-Triiodothyronine
Blanchard, K. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031971 · Cited by 10
Triiodothyronine alongside levothyroxine in the management of hypothyroidism?
Gottwald-Hostalek, U., & Kahaly, G. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1984219 · Cited by 9
Vargas‐Uricoechea, H., & Wartofsky, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179218 · Cited by 15
Phan, G. Q., Yavuz, S., Stamatouli, A. M., Madan, R., Chen, S., Grover, A. C., Nilubol, N., Bedoya, P., Trankle, C. R., Markley, R., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1522753 · Cited by 9
Bjerkreim, B. A., Hammerstad, S. S., Gulseth, H. L., Berg, T. J., Lee-Ødegård, S., Rangberg, A., Jonassen, C. M., Budge, H., Morris, D. E., Law, J., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.785175 · Cited by 10
Ala, S., Akha, O., Kashi, Z., Bahar, A., Rad, H. A., Sasanpour, N., & Shiva, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/156375 · Cited by 10
NHG-Standaard Schildklieraandoeningen
Wessels, P., van Rijswijk, E., Boer, M. A., & van Lieshout, J. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6614-9_86 · Cited by 9
Bjerkreim, B. A., Hammerstad, S. S., Gulseth, H. L., Berg, T. J., Lee-Ødegård, S., & Eriksen, E. F. (2022) · Journal of Thyroid Research · doi:10.1155/2022/6423023 · Cited by 8
Carmichael, J. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380926-1.10010-0 · Cited by 8
Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism
Jonklaas, J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.12.003 · Cited by 10
Lowe, J. C., & Yellin, J. (2008) · Cited by 7
Pappy, A. L., Oyesiku, N. M., & Ioachimescu, A. G. (2016) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709616661834 · Cited by 8
“8-20 This prompted our further investigation as to why the physician prescribing the compounded T4/T3 chose these doses.”
BackgroundResultCombined therapy with levothyroxine and liothyronine for hypothyroidism
Fischman, A., & Domínguez, J. M. (2018) · Medwave · doi:10.5867/medwave.2018.08.7375 · Cited by 7
Gottwald-Hostalek, U., & Tayrouz, Y. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2435460 · Cited by 6
Metabolic Systemic Effects Triiodothyronine
Troshina, E. A., & Семеновна, С. Е. (2020) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2020-10-4-262-271 · Cited by 9
“Во многих исследованиях [14, 19-25] было показано, что комбинированная терапия (левотироксин натрия + лиотиронин) не имеет преимуществ по сравнению с монотерапией левотироксином натрия.”
Jonklaas, J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_19 · Cited by 6
Alternative and Complementary Treatment of Thyroid Disorders
Onumah, B. M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3314-3_69 · Cited by 6
Effect of aerobic training on depression and thyroid function in treated hypothyroid women
Elgayar, S. L. (2023) · Revista Pesquisa em Fisioterapia · doi:10.17267/2238-2704rpf.2023.e5254 · Cited by 7
Monitorización del tratamiento con tiroxina en el hipotiroidismo primario y central
Sesmilo, G. (2005) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(05)71032-9 · Cited by 8
Lowe, J. C. (2009) · Cited by 6
Pepper, G. M., & Casanova-Romero, P. Y. (2014) · Cited by 7
Guglielmi, R., Mian, C., Novizio, R., Paoletta, A., Persichetti, A., Samperi, I., Scoppola, A., Bagnasco, M., Menis, E. D., Rimini, M. L. D., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02652-y · Cited by 6
Hajtalebi, F., Alaei-Shahmiri, F., Golgiri, F., Shahini, N., Akbari, H., Assadian, K., & Mosalamiaghili, S. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01840-4 · Cited by 6
“Conversely, over the past two decades, several studies have reported that LT4 + LT3 combination therapy did not enhance patients’ quality of life [7, 10–12].”
Fussey, J. M., Khan, H., Ahsan, S. F., Prashant, R., & Pettit, L. (2017) · Head & Neck · doi:10.1002/hed.24926 · Cited by 5
Heald, A. H., Livingston, M. A., & Hughes, D. A. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1062-6167 · Cited by 5
Disfunción tiroidea y trastornos del ánimo: revisión del estado del arte
Caneo, C., Igor Aedo, C., Riquelme, M. J., & Fardella, C. (2020) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2020.01.003 · Cited by 7
Mehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01434-y · Cited by 6
Thyroid function disorders and cardiovascular system
Troshina, E. A., Yukina, M. Y., Ogneva, N. A., & Mazurina, N. V. (2010) · Clinical and experimental thyroidology · doi:10.14341/ket20106112-19 · Cited by 6
“Пять [18, 53, 56, 60, 66] проведенных до этого похожих ис следований также не выявили достоверных преиму ществ комбинированной терапии гипотиреоза.”
Potential uses of T3 in the treatment of human disease
Danzi, S. E., & Klein, I. L. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80052-3 · Cited by 6
Is the acquired hypothyroidism a risk factor for developing psychiatric disorders?
Brizuela, N. O., Peraza, A. V., Ángel, D. S.-D., García-Martínez, Y., Pacheco-Rosado, J., Pérez‐Sánchez, G., & Sánchez-Huerta, K. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1429255 · Cited by 7
Psychosocial Factors in Patients with Thyroid Disease
Mandincov, P. (2012) · InTech eBooks · doi:10.5772/36477 · Cited by 3
Eligar, V. S., Taylor, P. N., Okosieme, O. E., & Dayan, C. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00077-8 · Cited by 3
Sawka, A. M., & Gerstein, H. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032256 · Cited by 3
Self-citationJonklaas, J. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2492789 · Cited by 2
Лечение первичного гипотиреоза: нерешенные вопросы
Моргунова, Т. Б., Madiyarova, M. S., & Fadeyev, V. V. (2015) · Clinical and experimental thyroidology · doi:10.14341/ket2015122-34 · Cited by 4
McDermott, M., & Ridgway, E. C. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-5 · Cited by 4
Thyroid Anatomy and Physiology
Broughton, C., & Ahmad, B. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_26 · Cited by 4
Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy
Baran, J. A., Isaza, A. R., Bojarsky, M., Alzoebie, L., Song, M., Halada, S., Sisko, L., Gonzales, S., Mostoufi‐Moab, S., & Bauer, A. J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1443394 · Cited by 1
Options of Replacement Therapy in Hypothyroidism
Valentine, V., Galina, A., & Morgunov, T. (2012) · InTech eBooks · doi:10.5772/31226 · Cited by 1
Seifert, R. (2023) · Springer eBooks · doi:10.1007/978-3-662-68371-2_37 · Cited by 1
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
Social and Medical Aspects of Replacement Thyroxine Therapy: Factors of Compensation Quality
Моргунова, Т. Б., Manuilova, Y., & Fadeyev, V. V. (2007) · Clinical and experimental thyroidology · doi:10.14341/ket20073312-24 · Cited by 3
Psychiatric disorders and thyroid disease
Migdal, A. L., & Hennessey, J. V. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00050-4 · Cited by 1
Sawka, A. M., & Gerstein, H. C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032072 · Cited by 1
Self-citationZiegler, R., & Schwabe, U. (2006) · Springer eBooks · doi:10.1007/3-540-30505-x_45 · Cited by 1
Neuroendocrine functions, mood and quality of life
Mazza, M., & Mazza, S. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5779-3_3 · Cited by 3
Psychological well-being on thyroid hormone replacement
Saravanan, P. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33607804
T4 versus T3 and T4: Is It a Real Controversy?
Weetman, A. P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097569
Evidence Based Medicine in Endocrinology
Rhee, S. Y., & Kim, Y. S. (2008) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2008.23.6.379
“원발성 갑상선기능저하증에 대한 T3와 T4 병용요법[68,69]”
L-T4 and L-T3 combined treatment vs L-T4 alone
Wiersinga, W. M. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.008 · Cited by 2
Aus der Medizinischen Universitätsklinik und
Tübingen, P., & Medizin, A. I. (2005)
Guardado‐Mendoza, R. (2011) · Revista de Endocrinología y Nutrición · Cited by 8
Is combination therapy appropriate for hypothyroidism?
Linder, L., & Clements, J. N. (2015) · JAAPA · doi:10.1097/01.jaa.0000470438.14941.98
Baron, H. L., & SINGER, P. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50042-1 · Cited by 2
Thyroid Hormone Therapy and Thyrotropin Suppression
Wartofsky, L. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3314-3_36
Kant, R., & Verma, V. K. (2018) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000e127
“In some of these studies patients preferred combination LT4/LT3 even though no or minimal statistically significant differences were observed in primary outcomes [6-19].”
BackgroundÇaklılı, Ö. T. (2019) · Kocaeli Üniversitesi Sağlık Bilimleri Dergisi · doi:10.30934/kusbed.600302 · Cited by 2
Modalities of Thyroid Hormone Administration and Correlates Between Blood and Tissue Levels
Celi, F. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_26
Psychiatric Disorders and Thyroid Disease
Hennessey, J. V. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05885-8.00041-6
NHG-Standaard Schildklieraandoeningen: Eerste herziening
Wessels, P., van Rijswijk, E., Boer, A., & van Lieshout, J. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_71
Levothyroxine Therapy and Thyrotropin Suppression
Wartofsky, L. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-995-0_29
Thyroid Anatomy and Physiology
(2006) · Springer eBooks · doi:10.1007/1-84628-006-0_2
Adjuvante Schilddrüsenhormonbehandlung
Bauer, M., Köberle, U., & Whybrow, P. C. (2005) · Springer eBooks · doi:10.1007/3-540-28049-9_19
(2006) · Springer eBooks · doi:10.1007/1-84628-006-0_6
Ziegler, R., & Schwabe, U. (2007) · Springer eBooks · doi:10.1007/978-3-540-34370-7_44
Schlechte, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-2-200501180-00012
“A third study by Sawka and colleagues (4) focused on depression and compared the effects of a combination of T4 and T3 thearpy on depressive symptoms with T4 therapy alone.”
BackgroundA Clinical Audit of Thyroid Hormonal Replacement After Total Thyroidectomy
Mansy, I., Elsenosy, A. M., Hassan, E. M., & Abdelgader, M. Z. (2023) · Cureus · doi:10.7759/cureus.50374
“After thyroidectomy and treatment with an adjusted dose of THR, they had a normal post-treatment TSH with a mean of 1.22 ± 0.12 mIU/L. Sawka et al. [18] examined 40 patients receiving levothyroxine for primary hypothyroidism who also had depression symptoms.”
BackgroundInfluentialPerros, P. (2024) · Copernicus books · doi:10.1007/978-3-031-58287-5_6
Seifert, R. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_37
Mehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2024) · Figshare · doi:10.6084/m9.figshare.26613242
Nassar, M., Hassan, A., Ramadan, S., Desouki, M., Hassan, M. A., & Chaudhuri, A. (2024) · Figshare · doi:10.6084/m9.figshare.26733783
Seifert, R. (2026) · Springer eBooks · doi:10.1007/978-3-662-72738-6_37
Metadata
- Authors
- Sawka, A. M., Gerstein, H. C., Marriott, M. J., MacQueen, G. M., & Joffe, R. T.
- Affiliations
- McMaster University (CA)
- Hamilton Health Sciences (CA)
- St Joseph's Health Care (CA)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Gerstein, H. C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-10
- Volume
- 88
- Issue
- 10
- Pages
- 4551-4555
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2086555083
- Cited by
- 175
- References
- 26
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 4 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 7 · 2018: 8 · 2017: 4 · 2016: 11 · 2015: 5 · 2014: 6 · 2013: 6 · 2012: 9
- FWCI
- 8.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- McMaster University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- hypothyroidism, depressive symptoms, levothyroxine, triiodothyronine, combination thyroid hormone therapy, thyroid hormone replacement, mood, well-being, thyroid-stimulating hormone
- MeSH terms
- Adult, Affect, Depression, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Hypothyroidism, Male, Middle Aged, Thyroid Gland, Thyroxine, Triiodothyronine, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.